Journal of Cardiac Failure
Volume 12, Issue 6 , Pages 430-438 , August 2006

Validation of Prognostic Models Among Patients With Advanced Heart Failure

  • David S. Frankel, MD

      Affiliations

    • From the Massachusetts General Hospital, Boston, Massachusetts
    • ,
  • John D. Piette, PhD

      Affiliations

    • Center for Practice Management and Outcomes Research and University of Michigan, Ann Arbor, Michigan
    • ,
  • Mariell Jessup, MD, FACC

      Affiliations

    • Division of Cardiovascular Medicine, Heart Failure and Cardiac Transplant Program, University of Pennsylvania, Philadelphia, Pennsylvania
    • ,
  • Kimberly Craig, RN, JD

      Affiliations

    • Division of Cardiovascular Medicine, Heart Failure and Cardiac Transplant Program, University of Pennsylvania, Philadelphia, Pennsylvania
    • ,
  • Faith Pickering, RN

      Affiliations

    • Division of Cardiovascular Medicine, Heart Failure and Cardiac Transplant Program, University of Pennsylvania, Philadelphia, Pennsylvania
    • ,
  • Lee R. Goldberg, MD, MPH, FACC

      Affiliations

    • Division of Cardiovascular Medicine, Heart Failure and Cardiac Transplant Program, University of Pennsylvania, Philadelphia, Pennsylvania
    • Corresponding Author InformationReprint requests: Lee R. Goldberg, MD, MPH, Heart Failure and Cardiac Transplant Program, University of Pennsylvania, 6 Penn Tower, 3400 Spruce Street, Philadelphia, PA 19104.

Received 29 July 2005 ,Revised 25 March 2006 ,Accepted 28 March 2006.

References 

  1. American Heart Association . 2002 heart and stroke statistics. Dallas (TX): American Heart Association; 2001;
  2. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol. 1993;22:6A
  3. Hjalmarson A, Goldstein S, Fagerberg B, et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA. 2000;283:1295–1302
  4. The CONSENSUS Trial Study Group . Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316:1429–1435
  5. Quinones MA, Greenberg BH, Kopelen HA, et al. Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol. 2000;35:1237–1244
  6. Pinamonti B, Di Lenarda A, Sinagra G, Camerini F. Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by Doppler echocardiography: clinical, echocardiographic and hemodynamic correlations and prognostic implications. Heart Muscle Disease Study Group. J Am Coll Cardiol. 1993;22:808–815
  7. de Groote P, Millaire A, Foucher-Hossein C, et al. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. J Am Coll Cardiol. 1998;32:948–954
  8. Lee WH, Packer M. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation. 1986;73:257–267
  9. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA. 2003;290:2581–2587
  10. Bouvy ML, Heerdink ER, Leufkens HGM, Hoes AW. Predicting mortality in patients with heart failure: a pragmatic approach. Heart. 2003;89:605–609
  11. Alla F, Briancon S, Juilliere Y, et al. Differential clinical prognostic classifications in dilated and ischemic advanced heart failure: the EPICAL study. Am Heart J. 2000;139:895–904
  12. Cowie MR, Wood DA, Coats AJ, et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart. 2000;83:505–510
  13. Aaronson KD, Schwartz JS, Chen T, Wong K, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997;95:2660–2667
  14. Chin MH, Goldman L. Correlates of early hospital readmission or death in patients with congestive heart failure. Am J Cardiol. 1997;79:1640–1644
  15. Tierney WM, Takesue BY, Vargo DL, Zhou XH. Using electronic medical records to predict mortality in primary care patients with heart disease: prognostic power and pathophysiologic implications. J Gen Intern Med. 1996;11:83–91
  16. Scrutino D, Lagioia R, Ricci A, et al. Prediction of mortality in mild to moderately symptomatic patients with left ventricular dysfunction. The role of New York Heart Association classification, cardiopulmonary exercise testing, two-dimensional echocardiography and Holter monitoring. Eur Heart J. 1994;15:1089–1095
  17. McAlister FA, Lawson FM, Teo KK, et al. A systematic review of randomized trials of disease management programs in heart failure. Am J Med. 2001;110:378
  18. Pine M, Norusis M, Jones B, Rosenthal GE. Predictions of hospital mortality rates: a comparison of data sources. Ann Intern Med. 1997;126:347–354
  19. Goldberg LR, Piette JD, Walsh MN, et al. Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial. Am Heart J. 2003;146:705–712
  20. Jiang W, Alexander J, Christopher E, et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med. 2001;161:1849–1856
  21. Zugck C, Kruger C, Kell R, et al. Risk stratification in middle-aged patients with congestive heart failure: prospective comparison of the Heart Failure Survival Score (HFSS) and a simplified two-variable model. Eur J Heart Fail. 2001;3:577–585
  22. Rich MW, Beckham V, Wittenberg C, et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995;333:1190–1195
  23. Struthers AD, Anderson G, Donnan PT, et al. Social deprivation increases cardiac hospitalizations in chronic heart failure independent of disease severity and diuretic non-adherence. Heart. 2000;83:12–16
  24. Philbin EF, Dec GW, Jenkins PL, et al. Socioeconomic status as an independent risk factor for hospital readmission for heart failure. Am J Cardiol. 2001;87:1367–1371
  25. Weber KT, Janicki JS. Cardiopulmonary exercise testing: physiologic principles and clinical applications. Philadelphia: W.B. Saunders Co; 1986;p. 152
  26. Bittner V, Weiner DH, Yusuf S, et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. JAMA. 1993;270:1702–1707
  27. Ware JE, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–233
  28. Ware JE, Koskinski M, Keller SD. SF-12: how to score the SF-12 physical and mental health summary scales. 2nd ed.. Boston: The Health Institute, New England Medical Center; 1995;
  29. Bart BA, Shaw LK, McCants CB, et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol. 1997;30:1002–1008
  30. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334:1349–1355
  31. Packer M, Fowler MB, Roecker EB, et al. Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation. 2002;106:2194–2199
  32. Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomized trial. Lancet. 2001;357:1385–1390
  33. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353:9–13
  34. Brophy JM, Deslauriers G, Rouleau JL. Long-term prognosis of patients presenting to the emergency room with decompensated congestive heart failure. Can J Cardiol. 1994;10:543–547

PII: S1071-9164(06)00190-4

doi: 10.1016/j.cardfail.2006.03.010

Journal of Cardiac Failure
Volume 12, Issue 6 , Pages 430-438 , August 2006

Article Tools

* Image Usage & Resolution